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ABSTRACT
The yeast two-hybrid system was used to screen a
library of random peptides fused to a transcriptional
activation domain in order to identify peptides capable
of binding to the retinoblastoma protein (Rb). Seven
peptides were identified, all of which contain the
Leu-X-Cys-X-Glu motif found in Rb-binding proteins,
although their activity in the yeast assay varied over a
40-fold range. Mutagenesis of the DNA encoding two
of these peptides followed by screening in the two-
hybrid system allowed the delineation of residues
apart from the invariant Leu, Cys and Glu that affect
binding to Rb. Binding affinities of a peptide and one
of its variants to Rb, determined by surface plasmon
resonance, correlated with results from the two-hybrid
assay. This method offers several advantageous fea-
tures compared to existing technology for screening
peptide libraries: in vivo detection of protein-peptide
interactions, high sensitivity, the capacity for rapid
genetic screening to identify stronger and weaker
binding peptide variants, and the use of a simple assay
(transcriptional activity) as a means to assess binding
affinity.
INTRODUCTION
Combinatorial libraries of macromolecules are finding increasing
use as a means to identify ligands for biologically important targets.
In particular, diverse approaches have been developed for the
generation of large arrays of random peptides. These include
libraries synthesized in vivo and displayed on the surface of a
filamentous phage (1-3) or at the carboxy terminus of the lac
repressor protein (4), and others synthesized chemically and
coupled to resin beads (5). Biologically-derived peptide libraries
are screened by sequential rounds of affinity enrichmeht
('panning'). Phage display libraries allow very complex mixtures
of peptides to be screened; peptides with the relevant binding
activity initially present at low abundance are amplified in
subsequent rounds of infection. The primary structure of the
specific peptides are then identified by DNA sequence analysis of
the phage DNA. By contrast, peptides identified from chemically-
derived libraries are generally characterized by Edman degradation
(5) or by the analysis of molecular tags that had been attached to
the beads for recording steps of the synthesis (6,7). These libraries
have the advantage of allowing the incorporation of unnatural
amino acids into the peptides. Recently, an in vitro polysome
display system has been designed to select peptide ligands from
1012 random peptides (8). All ofthese methods detectprotein-pep-
tide binding under in vitro conditions, and require further
biochemical experiments to determine affinity values for peptides
identified in the random screen. Additionally, they have limited
capacity for rapid discrimination of tighter or weaker binding
variants. We describe here the use of a peptide library in the yeast
two-hybrid system (9,10) which has unique features relative to
existing technology.
The two-hybrid system relies on the modular nature of many
eukaryotic site-specific transcriptional activators to generate a
transcriptional signal from the interaction of a protein fused to a
DNA-binding domain with another protein fused to a transcription
activation domain. Unlike other methods, the two-hybrid system
detects protein-protein interactions occurring in vivo. This leads to
a high degree of sensitivity [see for example (11,12)], presumably
due to an ampliflcation effect in which a transient interaction can
lead to multiple rounds of transcription and translation and the
production of stable reporter proteins such as E.coli P-galactosi-
dase. Furthermore, as a microbially-based assay, this system allows
both the direct selection of only those yeast transformants that
express a desired protein-protein interaction as well as the use of
simple genetic strategies to identify small protein domains or single
amino acid residues critical for such an interaction (11,12).
MATERIALS AND METHODS
DNA constructions and mutagenesis
Plasmids encoding the activation domain hybrids with T antigen
peptides were generated by PCR amplification of the indicated T
antigen sequences. The LTP hybrid was generated in pGAD.GH
(13) and the LTP-Leu hybrid in pGAD424 (14). The peptide
library was generated using the oligonucleotide 5'-GAAC-
TAGTGGATTCCC(NNK)16TAGGAATTCGGCCGC-3' (N is
an equal mixture of all four deoxynucleotides; K is an equal
mixture of G and T) to encode 16 random codons flanked by DNA
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sequences containing BamHI and EcoRl restriction sites. PCR
amplification was performed using 26 pmol oligonucleotide and 6
nmol of the primers 5'-GAACTAGTGGATTCCC-3' and
5'-GCGGCCGAATTCCTA-3'. After digestion with BamHI and
EcoRI, fragments were ligated into pGAD.GH and electroporated
into the E.coli strain DH5Sa to generate a library with -107 inserts.
Fifty plasmids were randomly chosen and sequenced. All contained
inserts; -15% of the inserts encoded peptides of <16 residues, due
to the presence of termination codons generally resulting from a
missing nucleotide in the oligonucleotide synthesis.
To generate hybrids of a peptide with the Gal4 DNA-binding
domain, the multiple cloning site in the vector pGBT9 (14) was
modified to match to that ofthe pGAD.GH. The EcoRI ofpGBT9
was changed to a SpeI site using the adaptor 5'-AATACTAGT-3',
and then the SpeI-SalI fragment of the plasmid pBS SK +
(Stratagene Co., San Diego, USA) containing the multiple
cloning site was inserted into the SpeI/SalI sites to generate
pGBT9BS. DNA sequences encoding peptides P1, P1-al, P7, and
P7-14 in the vector pGAD.GH were isolated as BamHI-EcoRI
fragments and ligated into pGBT9BS.
To create a fusion of glutathione S-transferase to Rb residues
301-928, the EcoRI site of pGEX-3X (Pharmacia, Uppsala,
Sweden) was changed to a SatI site using the adaptor
5'-AATTGTCGAC-3', and the BamHI-SalI fragment of
pASRb2 (15) was inserted into this vector.
Mutations were generated by using PCR under suboptimal
conditions as described (16).
Yeast methods
The yeast reporter strain Y153 (14) was transformed and
screened for His+ lacZ+ colonies, plasmids were recovered and
analyzed, and 0-galactosidase activity was determined as de-
scribed (17). Values for liquid f-galactosidase assays represent
the mean of at least four assays, and the standard errors were
generally 10-20% of the mean.
Surface plasmon resonance analysis
The GST-Rb fusion was purified as described (18). Peptides
were purchased from Quality Controlled Biochemicals, Inc.
(Hopkinton, MA). Binding kinetics were determined by surface
plasmon resonance (BlAcore, Pharmacia Biosensor). Purified
GST-Rb was diluted to 15 jg/ml in sodium acetate buffer (10
mM, pH 4.5) and was coupled to the dextran-modified gold
surface of aCM5 sensor chip (Pharmacia Biosensor) using.amine
coupling chemistry [N-hydroxysuccinimide/N-ethyl-N-(3-dime-
thylaminopropyl)-carbodiimide] as described in the system
manual. Peptides were dissolved in 10mMNaOH and the pH was
adjusted to 7.4 prior to being diluted to the desired concentrations
in HBS buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 3.4 mM
EDTA, 0.005% Surfactant P-20) containing 100 ,ug/ml BSA.
Serial dilutions of each peptide (1-10 jM of P1 and 5-50 jiM of
P1-al) were injected over the GST-Rb coupled surface at 8
gl/min. Sensorgrams were recorded and normalized to a baseline
of0 resonance units (RU). Data were fitted to a single site binding
model of A + B = AB by non-linear least squares curve fitting
using BlAevaluation 2.0 software (Pharmacia Biosensor). The
equation Rt = Ro x exp[-koffx (t-to)] was used for the dissociation
phase, where Rt was the amount bound in RU at time t, and to was
the beginning of the dissociation phase. In one experiment, the
dissociation rate constant (koff) of P1 binding was (5.03 ± 0.35)
x 10-3 s-1, and ofP1-al binding was (1.13 ± 0.05) x 10-2 s-1). The
equation Rt = Req x { 1 - exp[-ks x (t-to)]} was used for the
association phase, where ks = kon x C + koff and the association
rate constant kon was calculated by the linear curve fitting ofa plot
of ks versus C. Req was the amount bound in RU at equilibrium,
to was the time that injection started, and C was the concentration
of peptide injected. In one experiment, for P1, kon = (3.77 ± 0.20)
x 102 M-1 s-I (correlation coefficient, R = 0.983) and for P1-al,
kon = (1.48 ± 0.12) x 102 M-1 s-I (R = 0.974). For this experiment,
the equilibrium constants KD (calculated from the ratio koff/kon)
are 13.3 ,uM for P1 and 76.4jM for P1-al . KD was also calculated
by the linear curve fitting of a plot of Req versus Req/C using the
equation Req/C = 1/KD x Rmax-l/KD x Req, where Rmax is the
maximum binding in RU when the surface is saturated and Req
was calculated as above.
RESULTS AND DISCUSSION
Identification of Rb-binding peptides
To test the feasibility of the two-hybrid system to detect
protein-peptide interactions, we chose to analyze the binding of
small peptides to the human retinoblastoma (Rb) protein. Rb binds
to viral oncogene products such as SV40 large T antigen,
adenovirus EIA and human papilloma virus E7 and to cellular
proteins such as D-type cyclins (19). Rb-binding in these cases is
mediated by the amino acid motif Leu-X-Cys-X-Glu (20-23).
We generated Gal4 activation domain hybrids that contain peptides
from SV40 large T antigen: the LTP (for Large T antigen Peptide)
hybrid contains residues 103-115, which begins with the Leu ofthe
conserved motif, and the LTP-Leu hybrid contains residues
104-115 (Table 1). The plasmid pASRb2 (15) encodes residues
301-918 ofRb fused to the Gal4 DNA-binding domain (BD-Rb).
When the hybrid proteins LTP and BD-Rb were co-expressed in
a yeast reporter strain, binding of the T antigen peptide to Rb was
observed as substantial 0-galactosidase activity (Table 1). By
contrast, the LTP-Leu construct resulted in only background
transcriptional activity (Table 1), indicating that protein-peptide
interactions can be specifically detected in two-hybrid assays.
Table 1. A peptide from SV40 large T antigen and peptides identified from a












aPeptide sequences are aligned by the conserved residues (indicated in bold);
LTP is derived from SV40 large T antigen.
bActivity was determined as in (17).










charge of -5 but only a single hydrophobic residue outside the
invariant motif. The similar activity of P1 and the large T antigen
peptide may be due to the presence of a negatively charged
residue immediately C-terminal to the conserved motif. Figge et
al. (22) analyzed the sequences of the Rb-binding domain from
21 proteins and derived a consensus that includes a net negative
charge flanking the conserved motif, a bias against Lys and Arg
residues, and an overall hydrophobic nature. However, their
consensus includes such features as an Asp, Asn or Thr
immediately N-terminal to the conserved Leu, as well as a Glu or
Asp one to three residues N-terminal to the conserved Leu; these
features are not found in the P1 peptide.
reporter
strain G1 binclng site HS3 or lac
Sequence DNA encoing peptide
Figure 1. Screen for Rb-binding peptides. One plasmid encodes a fusion of the
Gal4 DNA-binding domain (residues 1-147) to a large domain of Rb; the other
plasmid is used to generate a library of 16-long peptides (encoded by NNK, N
is all four nucleotides and K is G and T) fused to the Gal4 activation domain
(residues 768-881). The Rb plasmid and the library are introduced into a yeast
strain containing HIS3 and lacZ genes under the regulation of Gal4 binding
sites. Positive yeast transformants are identified and for each, the DNA
sequence encoding the peptide is determined.
We constructed a library of 16-residue long peptides fused to
the Gal4 activation domain and screened it to identify Rb-binding
peptides (Fig. 1). The library was generated by cloning a pool of
random oligonucleotides into the Gal4 activation domain vector
pGAD.GH (13); the total complexity was 107. Statistically, the
library should encompass at least all possible pentamer peptides.
We cotransformed this library with pASRb2, encoding the Gal4
DNA-binding domain fusion to Rb, into a yeast reporter strain;
selection was for the ability of transformants to grow in the
absence of histidine by virtue of the expression of the Gal4-
dependent gene GALJ-HIS3. His+ colonies were also screened
by a filter lift assay for expression of another Gal4-dependent
gene GALJ-lacZ. Of three million transformants, seven peptides
that bind to Rb were identified (Table 1).
All seven peptides contain the conserved Leu-X-Cys-X-Glu
motif. However, transcriptional activity in the two-hybrid assay
varied more than 40-fold, indicating that residues other than the
three invariant ones play a role in determining this activity.
Notably, the five peptides producing the most P-galactosidase
activity have a high net negative charge (average -2.6) and
contain no Arg or Lys residues. In contrast, P6 has an overall
charge of-1 and contains a single Lys residue, and P7 is overall
neutral and contains three Arg residues (Table 1). Additionally,
the peptides producing the most activity tend to be hydrophobic
in nature. Thus P1, with a net charge of -4 and six hydrophobic
residues (apart from the invariant Leu and Cys), produced more
than 7-fold greater f3-galactosidase activity than did P4, with a net
Affinity analysis
To analyze the role of residues other than the conserved motif, we
took advantage of the ability in the two-hybrid system to readily
detect changes in transcriptional activity as colonies that are darker
or lighter blue in the Xgal filter assay. We randomly mutagenized
the peptide P1, displaying greatest activity, and P7, with least
activity, by amplifying their corresponding oligonucleotides using
suboptimal PCR (16) and cloning of the PCR products into the
activation domain vector. We obtained six peptides derived from
P1 that produced less P-galactosidase activity than P1, and two that
produced similar activity (Table 2). All six with decrased activity
have a mutation that leads to a +1 change in charge, either by loss
of an Asp or Glu or gain of an Arg. The two peptides with similar
activity to P1 have no net change in charge. For P7, the two mutants
with increased activity have additional negative charge; change of
an Arg residue to a neutral residue (Gly) doubled the activity
whereas change of this residue to an acidic residue (Glu) led to
more than a 3-fold increase (Table 2).




P1 Y G L W I L W C D Z E G L D L G 45
PI-r - - - - T - - - - - - - - - - - 45
P1-a - - - - - - - - E - - - - - - - 42
P1-h - - - R- - - - - - - - - - - - 27
P1-i - - - - - - R - - - - - - - - - 22
P1-i - - - - - - - - - - - - - G - - 18
P1-20 - - - - - - - - G - - - - - - - 16
P1-K - - - - - - - - - - G - - - - - 12
P1-al - - R - - - - - - - - - - - - - 11
P7 T T W R E R L R C E Z N G L G V 2.2
P7-7 - - - G- - - - - - - - - - - - 4.4
P7-14 - - - E- - - - - - - - - - - - 7.3
To compare the two-hybrid results with biochemical affinity
determinations, we synthesized the peptides P1, P1-al, P7 and
P7-14 (Table 2) and purified .Rb from E.coli as a glutathione
S-transferase fusion protein. Association and dissociation kin-
etics were measured using surface plasmon resonance technology
(24) with a BIAcore system (Pharmacia Biosensor). P1 bound to
Rb with an apparent KD of 13-23 jiM, and P1-al with an apparent
Nucleic Acids Research, 1995, Vol. 23, No. 7 1155
KD of 61-76 gM. The binding of neither P7 nor P7-14 could be
detected by this assay. These results correlate well with our initial
identification ofP1 and P7 as peptides producing the greatest and
least P-galactosidase activities, respectively. Additionally, P1
produced 4.2-fold more activity in the two-hybrid assay than the
P1-al mutant identified as having lower activity; this result
compares with the -4-fold effect in the BIAcore binding assay.
These binding data suggest that the two-hybrid assay can detect
affinities well above -70 IM, which compares with KD values as
high as 100-500 jM that can be detected with phage and Lacd
display systems (25).
Use of peptides in DNA-binding domain hybrids
We switched the orientation of the Rb domain and selected
peptides such that the Rb domain was fused to the Gal4 activation
domain (AD-Rb) and the peptide to the Gal4 DNA-binding
domain. For the combinations that included P7 and its mutant
P7-14, the two-hybrid transcriptional signals (Table 3) were
similar to those with the original orientation (Table 2). These
results indicate that small peptides could serve as potential targets
in a two-hybrid approach to identify proteins that bind to a peptide
of interest. For the P1 peptide, the DNA-binding domain alone
produced substantial transcriptional activity, possibly due to the
high negative charge of the peptide. We obtained much greater
(-galactosidase activity when AD-Rb was co-expressed (Table
3), indicating that binding between Rb and the peptide occurred.
However, the two P1 mutants produced reduced transcription
both in the absence and presence ofAD-Rb compared to the wild
type P1 sequence (Table 3). Therefore, it is not possible to use the
two-hybrid assay with peptides of this type to assess their binding
affinities to some protein, as mutations can affect intrinsic
transactivation capacity as well as protein-peptide interaction.
Table 3. Peptides can function in the two-hybrid assay as fusions with the
Gal4 DNA-binding domain








The combinatorial peptide library we describe here allows the
identification of specific peptides in a single round of screening.
Furthermore, the peptides bind to their target proteins within the
cellular milieu, an advantageous feature for peptides that are
designed for in vivo uses. Biochemical analysis of protein-
peptide binding correlates well with the two-hybrid results,
indicating that rapid assessments of affmnity can be performed
using the yeast assay. These features suggest that the two-hybrid
system may have relevance for drug discovery schemes based on
the identification of peptides with affinity for selected proteins.
Initially, peptides identified in the two-hybrid assay may have low
binding affinity. However, the sequence of these peptides may
suggest a consensus for binding. In a second stage, mutagenesis
of individual peptides and rapid rescreening in yeast can be
performed. This stage can determine which residues are critical
for binding and which residues can be mutated without loss of
binding. It may also identify new peptides with increased affinity.
Ultimately, the peptides identified as having the highest affinity
might form the basis for the synthesis of mimetics to be used as
therapeutic agents.
It should also be feasible to design simple genetic assays to
identify peptide variants capable of binding to one target protein
but not to another. For example, it might be possible to identify
peptides that discriminate between wild type and mutant versions
of a protein. The two-hybrid assay might also be capable of
identifying peptides that can inhibit specific protein-protein
interactions; such peptides could be synthesized within cells to
examine the phenotypic consequences.
While the peptides used in these applications have a free
carboxy terminus, it is likely that the peptide moiety can also
function when present at the amino terminus ofthe hybrid protein.
In either of these cases, one end of the peptide would be
unconstrained by other portions of the polypeptide. However, it
should also be feasible to construct the peptide library such that
the insertion is flanked at both ends by domains of the polypeptide
such that the peptide is embedded in a rather rigid structure.
In contrast to some phage display libraries, there is no limit to
the number of residues that can comprise the peptide in the
two-hybrid assay. Finally, peptides found in screening an
activation domain library can themselves be used as targets in a
two-hybrid search to identify cellular proteins capable of binding
these peptides.
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